Bristol Myers Squibb Shakes Up Key Biotech Battleground Cheapest Gadget September 23, 2022 All No Comments Unlike smaller peers, the titans of the pharma industry don’t always get a share-price boost after earning an FDA approval. Bristol Myers Squibb (BMY) certainly did. The $150 billion … [Continue Reading...]